Martin P Carroll

12PUBLICATIONS
133CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyMetabolic medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 24, 2025
Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate.

Roberta Buono, Dennis Juarez, Madhuri Paul

|Jul 09, 2025
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response.

Sarah J Skuli, A'ishah Bakayoko, Marisa Kruidenier

|Oct 07, 2024
Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia.

Fiona C Brown, Xin Wang, Richard Birkinshaw

|May 07, 2024
A mitochondrial surveillance mechanism activated by <i>SRSF2</i> mutations in hematologic malignancies.

Xiaolei Liu, Sudhish A Devadiga, Robert F Stanley

|Feb 08, 2024
Human IL-6 fosters long-term engraftment of patient derived disease-driving myeloma cells in immunodeficient mice.

Zainul S Hasanali, Alfred L Garfall, Lisa Burzenski

|Nov 14, 2023
A Phase I Trial of Sirolimus with "7&3" Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia.

Neil Palmisiano, Grace Jeschke, Lindsay Wilde

Pageof 2

Frequent Collaborators

3 joint publications

Pamela J Sung

2 joint publications

Mathieu Quesnel-Vallières

2 joint publications

David A Fruman

2 joint publications

Jean-Emmanuel Sarry